UniProt ID | ECI2_HUMAN | |
---|---|---|
UniProt AC | O75521 | |
Protein Name | Enoyl-CoA delta isomerase 2, mitochondrial | |
Gene Name | ECI2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 394 | |
Subcellular Localization |
Isoform 1: Mitochondrion. Isoform 2: Peroxisome matrix. |
|
Protein Description | Able to isomerize both 3-cis and 3-trans double bonds into the 2-trans form in a range of enoyl-CoA species. Has a preference for 3-trans substrates (By similarity).. | |
Protein Sequence | MAMAYLAWRLARRSCPSSLQVTSFPVVQLHMNRTAMRASQKDFENSMNQVKLLKKDPGNEVKLKLYALYKQATEGPCNMPKPGVFDLINKAKWDAWNALGSLPKEAARQNYVDLVSSLSPSLESSSQVEPGTDRKSTGFETLVVTSEDGITKIMFNRPKKKNAINTEMYHEIMRALKAASKDDSIITVLTGNGDYYSSGNDLTNFTDIPPGGVEEKAKNNAVLLREFVGCFIDFPKPLIAVVNGPAVGISVTLLGLFDAVYASDRATFHTPFSHLGQSPEGCSSYTFPKIMSPAKATEMLIFGKKLTAGEACAQGLVTEVFPDSTFQKEVWTRLKAFAKLPPNALRISKEVIRKREREKLHAVNAEECNVLQGRWLSDECTNAVVNFLSRKSKL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MAMAYLAWRLAR ---CHHHHHHHHHHH | 5.49 | 24043423 | |
39 | Phosphorylation | NRTAMRASQKDFENS CHHHHHHHHHHHHHH | 27.65 | 24719451 | |
41 | Acetylation | TAMRASQKDFENSMN HHHHHHHHHHHHHHH | 62.99 | 71295 | |
47 | Sulfoxidation | QKDFENSMNQVKLLK HHHHHHHHHHHHHHH | 6.49 | 21406390 | |
51 | Acetylation | ENSMNQVKLLKKDPG HHHHHHHHHHHCCCC | 38.04 | 19608861 | |
51 | Succinylation | ENSMNQVKLLKKDPG HHHHHHHHHHHCCCC | 38.04 | - | |
51 | Succinylation | ENSMNQVKLLKKDPG HHHHHHHHHHHCCCC | 38.04 | - | |
51 | Malonylation | ENSMNQVKLLKKDPG HHHHHHHHHHHCCCC | 38.04 | 26320211 | |
54 | Acetylation | MNQVKLLKKDPGNEV HHHHHHHHCCCCCHH | 66.62 | 23749302 | |
55 | Succinylation | NQVKLLKKDPGNEVK HHHHHHHCCCCCHHH | 69.95 | - | |
55 | Succinylation | NQVKLLKKDPGNEVK HHHHHHHCCCCCHHH | 69.95 | - | |
60 (in isoform 2) | Ubiquitination | - | 47.12 | 21890473 | |
62 (in isoform 2) | Ubiquitination | - | 33.45 | 21890473 | |
62 | Succinylation | KDPGNEVKLKLYALY CCCCCHHHHHHHHHH | 33.45 | - | |
62 | Succinylation | KDPGNEVKLKLYALY CCCCCHHHHHHHHHH | 33.45 | - | |
62 | Acetylation | KDPGNEVKLKLYALY CCCCCHHHHHHHHHH | 33.45 | 23749302 | |
62 | 2-Hydroxyisobutyrylation | KDPGNEVKLKLYALY CCCCCHHHHHHHHHH | 33.45 | - | |
64 | Acetylation | PGNEVKLKLYALYKQ CCCHHHHHHHHHHHH | 33.46 | 25953088 | |
64 | Malonylation | PGNEVKLKLYALYKQ CCCHHHHHHHHHHHH | 33.46 | 26320211 | |
66 | Phosphorylation | NEVKLKLYALYKQAT CHHHHHHHHHHHHHC | 7.93 | 26356563 | |
69 | Phosphorylation | KLKLYALYKQATEGP HHHHHHHHHHHCCCC | 7.90 | 29496907 | |
70 | Acetylation | LKLYALYKQATEGPC HHHHHHHHHHCCCCC | 34.02 | 25953088 | |
70 | Succinylation | LKLYALYKQATEGPC HHHHHHHHHHCCCCC | 34.02 | - | |
70 | Succinylation | LKLYALYKQATEGPC HHHHHHHHHHCCCCC | 34.02 | - | |
73 | Phosphorylation | YALYKQATEGPCNMP HHHHHHHCCCCCCCC | 38.69 | 28842319 | |
81 | Acetylation | EGPCNMPKPGVFDLI CCCCCCCCCCHHHHH | 43.57 | 26051181 | |
81 | Succinylation | EGPCNMPKPGVFDLI CCCCCCCCCCHHHHH | 43.57 | - | |
81 | Succinylation | EGPCNMPKPGVFDLI CCCCCCCCCCHHHHH | 43.57 | - | |
90 | Acetylation | GVFDLINKAKWDAWN CHHHHHHHHHHHHHH | 44.33 | 25953088 | |
90 | Succinylation | GVFDLINKAKWDAWN CHHHHHHHHHHHHHH | 44.33 | - | |
90 | Succinylation | GVFDLINKAKWDAWN CHHHHHHHHHHHHHH | 44.33 | - | |
90 (in isoform 1) | Ubiquitination | - | 44.33 | 21890473 | |
90 | Ubiquitination | GVFDLINKAKWDAWN CHHHHHHHHHHHHHH | 44.33 | 21890473 | |
92 | Succinylation | FDLINKAKWDAWNAL HHHHHHHHHHHHHHH | 47.41 | - | |
92 | Succinylation | FDLINKAKWDAWNAL HHHHHHHHHHHHHHH | 47.41 | - | |
92 | Acetylation | FDLINKAKWDAWNAL HHHHHHHHHHHHHHH | 47.41 | 19608861 | |
92 | Malonylation | FDLINKAKWDAWNAL HHHHHHHHHHHHHHH | 47.41 | 26320211 | |
92 (in isoform 1) | Ubiquitination | - | 47.41 | 21890473 | |
92 | Ubiquitination | FDLINKAKWDAWNAL HHHHHHHHHHHHHHH | 47.41 | 19608861 | |
101 | Phosphorylation | DAWNALGSLPKEAAR HHHHHHCCCCHHHHH | 42.20 | 30108239 | |
104 | Acetylation | NALGSLPKEAARQNY HHHCCCCHHHHHHCH | 66.34 | 20167786 | |
116 | Phosphorylation | QNYVDLVSSLSPSLE HCHHHHHHHCCCCCC | 32.62 | 20873877 | |
117 | Phosphorylation | NYVDLVSSLSPSLES CHHHHHHHCCCCCCC | 25.95 | 29116813 | |
119 | Phosphorylation | VDLVSSLSPSLESSS HHHHHHCCCCCCCCC | 17.87 | 29116813 | |
121 | Phosphorylation | LVSSLSPSLESSSQV HHHHCCCCCCCCCCC | 41.20 | 20873877 | |
124 | Phosphorylation | SLSPSLESSSQVEPG HCCCCCCCCCCCCCC | 40.35 | 30576142 | |
125 | Phosphorylation | LSPSLESSSQVEPGT CCCCCCCCCCCCCCC | 18.53 | 26471730 | |
126 | Phosphorylation | SPSLESSSQVEPGTD CCCCCCCCCCCCCCC | 47.74 | 26471730 | |
135 | Ubiquitination | VEPGTDRKSTGFETL CCCCCCCCCCCCCEE | 56.00 | - | |
136 | Phosphorylation | EPGTDRKSTGFETLV CCCCCCCCCCCCEEE | 34.36 | 30266825 | |
137 | Phosphorylation | PGTDRKSTGFETLVV CCCCCCCCCCCEEEE | 49.26 | 30266825 | |
141 | Phosphorylation | RKSTGFETLVVTSED CCCCCCCEEEEECCC | 23.69 | 30266825 | |
152 | Acetylation | TSEDGITKIMFNRPK ECCCCCEEEEECCCC | 30.19 | 7683033 | |
159 | Acetylation | KIMFNRPKKKNAINT EEEECCCCCCCCCCH | 73.48 | 24886695 | |
159 | Succinylation | KIMFNRPKKKNAINT EEEECCCCCCCCCCH | 73.48 | 27452117 | |
160 | Acetylation | IMFNRPKKKNAINTE EEECCCCCCCCCCHH | 54.68 | 2403911 | |
161 | Succinylation | MFNRPKKKNAINTEM EECCCCCCCCCCHHH | 58.71 | 27452117 | |
161 | Malonylation | MFNRPKKKNAINTEM EECCCCCCCCCCHHH | 58.71 | 26320211 | |
161 | Acetylation | MFNRPKKKNAINTEM EECCCCCCCCCCHHH | 58.71 | 25038526 | |
161 | Succinylation | MFNRPKKKNAINTEM EECCCCCCCCCCHHH | 58.71 | - | |
166 | Phosphorylation | KKKNAINTEMYHEIM CCCCCCCHHHHHHHH | 18.93 | - | |
169 | Phosphorylation | NAINTEMYHEIMRAL CCCCHHHHHHHHHHH | 7.06 | 25219547 | |
218 | Malonylation | GGVEEKAKNNAVLLR CCHHHHHHHCCCHHH | 62.90 | 26320211 | |
278 | Phosphorylation | PFSHLGQSPEGCSSY CCHHCCCCCCCCCCC | 24.10 | 28152594 | |
283 | Phosphorylation | GQSPEGCSSYTFPKI CCCCCCCCCCCCCCC | 36.92 | 28152594 | |
284 | Phosphorylation | QSPEGCSSYTFPKIM CCCCCCCCCCCCCCC | 32.06 | 28152594 | |
285 | Phosphorylation | SPEGCSSYTFPKIMS CCCCCCCCCCCCCCC | 8.98 | 28152594 | |
286 | Phosphorylation | PEGCSSYTFPKIMSP CCCCCCCCCCCCCCC | 35.09 | 28152594 | |
289 | Acetylation | CSSYTFPKIMSPAKA CCCCCCCCCCCCCCC | 47.02 | 26051181 | |
289 | Succinylation | CSSYTFPKIMSPAKA CCCCCCCCCCCCCCC | 47.02 | - | |
289 | Succinylation | CSSYTFPKIMSPAKA CCCCCCCCCCCCCCC | 47.02 | - | |
299 | Sulfoxidation | SPAKATEMLIFGKKL CCCCCCEEEECCCCC | 2.78 | 21406390 | |
304 | 2-Hydroxyisobutyrylation | TEMLIFGKKLTAGEA CEEEECCCCCHHHHH | 33.58 | - | |
304 | Acetylation | TEMLIFGKKLTAGEA CEEEECCCCCHHHHH | 33.58 | 25953088 | |
305 | 2-Hydroxyisobutyrylation | EMLIFGKKLTAGEAC EEEECCCCCHHHHHH | 51.99 | - | |
305 | Malonylation | EMLIFGKKLTAGEAC EEEECCCCCHHHHHH | 51.99 | 26320211 | |
305 | Acetylation | EMLIFGKKLTAGEAC EEEECCCCCHHHHHH | 51.99 | 26051181 | |
312 | Glutathionylation | KLTAGEACAQGLVTE CCHHHHHHHHHCCEE | 2.24 | 22555962 | |
328 | Acetylation | FPDSTFQKEVWTRLK CCCCHHHHHHHHHHH | 50.47 | 25038526 | |
339 | Acetylation | TRLKAFAKLPPNALR HHHHHHHCCCCCHHH | 55.89 | 25953088 | |
349 | Ubiquitination | PNALRISKEVIRKRE CCHHHHCHHHHHHHH | 54.34 | - | |
359 | Acetylation | IRKREREKLHAVNAE HHHHHHHHHHCCCHH | 52.36 | 23749302 | |
359 | Malonylation | IRKREREKLHAVNAE HHHHHHHHHHCCCHH | 52.36 | 26320211 | |
359 | 2-Hydroxyisobutyrylation | IRKREREKLHAVNAE HHHHHHHHHHCCCHH | 52.36 | - | |
368 | Glutathionylation | HAVNAEECNVLQGRW HCCCHHHCCCCCCCC | 3.00 | 22555962 | |
393 | Acetylation | NFLSRKSKL------ HHHHHHHCC------ | 62.34 | 18527683 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ECI2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ECI2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ECI2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
KDM1A_HUMAN | KDM1A | physical | 23455924 | |
ECH1_HUMAN | ECH1 | physical | 26344197 | |
ECI2_HUMAN | ECI2 | physical | 27499296 | |
ECH1_HUMAN | ECH1 | physical | 27499296 | |
MCCA_HUMAN | MCCC1 | physical | 27499296 | |
IDE_HUMAN | IDE | physical | 27499296 | |
ACS2L_HUMAN | ACSS1 | physical | 27499296 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-51 AND LYS-92, AND MASSSPECTROMETRY. |